LY3045697

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY3045697, covering 2013-07-26 to 2013-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants [Phase 1]